GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 60 filers reported holding GAMIDA CELL LTD in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,300 | -46.6% | 10,000 | 0.0% | 0.01% | -36.4% |
| Q2 2023 | $19,300 | +138.3% | 10,000 | 0.0% | 0.01% | +120.0% |
| Q1 2023 | $8,100 | -37.2% | 10,000 | 0.0% | 0.01% | -37.5% |
| Q4 2022 | $12,900 | -19.4% | 10,000 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $16,000 | -11.1% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $18,000 | -57.1% | 10,000 | 0.0% | 0.01% | -45.5% |
| Q1 2022 | $42,000 | +68.0% | 10,000 | 0.0% | 0.02% | +83.3% |
| Q4 2021 | $25,000 | -35.9% | 10,000 | 0.0% | 0.01% | -40.0% |
| Q3 2021 | $39,000 | -39.1% | 10,000 | 0.0% | 0.02% | -39.4% |
| Q2 2021 | $64,000 | -60.5% | 10,000 | -50.0% | 0.03% | -29.8% |
| Q1 2021 | $162,000 | +92.9% | 20,000 | +100.0% | 0.05% | -2.1% |
| Q4 2020 | $84,000 | +100.0% | 10,000 | 0.0% | 0.05% | +54.8% |
| Q3 2020 | $42,000 | – | 10,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187 | $107,000,000 | 1.12% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 175,000 | $307,000 | 0.28% |
| Rock Springs Capital Management LP | 2,175,000 | $3,850,000 | 0.11% |
| Platform Technology Partners | 57,625 | $102,000 | 0.06% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,197,875 | $2,120,000 | 0.05% |
| Guild Investment Management, Inc. | 18,000 | $28,000 | 0.04% |
| MEITAV INVESTMENT HOUSE LTD | 429,352 | $760,000 | 0.01% |
| 1492 Capital Management LLC | 10,000 | $18,000 | 0.01% |
| ARK Investment Management | 714,534 | $1,558,000 | 0.01% |
| FEDERATED HERMES, INC. | 1,868,896 | $3,308,000 | 0.01% |